BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16869739)

  • 1. Ductal pancreatic cancer in humans and mice.
    Tuveson DA; Hingorani SR
    Cold Spring Harb Symp Quant Biol; 2005; 70():65-72. PubMed ID: 16869739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Precursors to pancreatic cancer].
    Søreide K; Immervoll H; Molven A
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
    Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
    Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN.
    Siveke JT; Einwächter H; Sipos B; Lubeseder-Martellato C; Klöppel G; Schmid RM
    Cancer Cell; 2007 Sep; 12(3):266-79. PubMed ID: 17785207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?
    Chandana S; Mahadevan D
    Expert Rev Mol Med; 2009 Nov; 11():e34. PubMed ID: 19919723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
    Haugk B
    Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer: a plea for good and comprehensive morphological studies.
    Algül H; Schmid RM
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):713-5. PubMed ID: 18617774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice.
    Osvaldt AB; Wendt LR; Bersch VP; Backes AN; de Cássia A Schumacher R; Edelweiss MI; Rohde L
    Surgery; 2006 Nov; 140(5):803-9. PubMed ID: 17084724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
    Izeradjene K; Combs C; Best M; Gopinathan A; Wagner A; Grady WM; Deng CX; Hruban RH; Adsay NV; Tuveson DA; Hingorani SR
    Cancer Cell; 2007 Mar; 11(3):229-43. PubMed ID: 17349581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An animal model of preclinical diagnosis of pancreatic ductal adenocarcinomas.
    Fukamachi K; Tanaka H; Hagiwara Y; Ohara H; Joh T; Iigo M; Alexander DB; Xu J; Long N; Takigahira M; Yanagihara K; Hino O; Saito I; Tsuda H
    Biochem Biophys Res Commun; 2009 Dec; 390(3):636-41. PubMed ID: 19818733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological analysis of oncogenic K-ras.
    Pérez-Mancera PA; Tuveson DA
    Methods Enzymol; 2006; 407():676-90. PubMed ID: 16757361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of pancreatic cancer.
    Maitra A; Kern SE; Hruban RH
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current topics on precursors to pancreatic cancer.
    Takaori K; Hruban RH; Maitra A; Tanigawa N
    Adv Med Sci; 2006; 51():23-30. PubMed ID: 17357272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of precursors to pancreatic cancer.
    Takaori K
    J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
    Gold DV; Karanjawala Z; Modrak DE; Goldenberg DM; Hruban RH
    Clin Cancer Res; 2007 Dec; 13(24):7380-7. PubMed ID: 18094420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer: translating lessons from mouse models and hereditary syndromes.
    Wescott MP; Rustgi AK
    Cancer Prev Res (Phila); 2008 Dec; 1(7):503-6. PubMed ID: 19138999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
    Hidalgo M; Von Hoff DD
    Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.